
Jessica Marie Prince
Examiner (ID: 16878, Phone: (571)270-1821 , Office: P/2486 )
| Most Active Art Unit | 2486 |
| Art Unit(s) | 2482, 2486, 2609, 2485, 2621 |
| Total Applications | 857 |
| Issued Applications | 606 |
| Pending Applications | 80 |
| Abandoned Applications | 190 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6938526
[patent_doc_number] => 20050112089
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Conjugate of biodegradable aliphatic polyester with TAT 49-57 peptide or peptide chain containing TAT 49-57 peptide and nanoparticle manufactured using the same'
[patent_app_type] => utility
[patent_app_number] => 11/027967
[patent_app_country] => US
[patent_app_date] => 2005-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6629
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20050112089.pdf
[firstpage_image] =>[orig_patent_app_number] => 11027967
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/027967 | Conjugate of biodegradable aliphatic polyester with TAT 49-57 peptide or peptide chain containing TAT 49-57 peptide and nanoparticle manufactured using the same | Jan 2, 2005 | Abandoned |
Array
(
[id] => 7039278
[patent_doc_number] => 20050158712
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-21
[patent_title] => 'Methods for purifying viral particles for gene therapy'
[patent_app_type] => utility
[patent_app_number] => 11/016560
[patent_app_country] => US
[patent_app_date] => 2004-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10624
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20050158712.pdf
[firstpage_image] =>[orig_patent_app_number] => 11016560
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/016560 | Methods for purifying viral particles for gene therapy | Dec 16, 2004 | Abandoned |
Array
(
[id] => 432151
[patent_doc_number] => 07264924
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2007-09-04
[patent_title] => 'Methods for detecting bacteriophage MS2'
[patent_app_type] => utility
[patent_app_number] => 11/010700
[patent_app_country] => US
[patent_app_date] => 2004-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7356
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 238
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/264/07264924.pdf
[firstpage_image] =>[orig_patent_app_number] => 11010700
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/010700 | Methods for detecting bacteriophage MS2 | Dec 1, 2004 | Issued |
Array
(
[id] => 428510
[patent_doc_number] => 07267943
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2007-09-11
[patent_title] => 'Methods for detecting bacteriophage MS2'
[patent_app_type] => utility
[patent_app_number] => 11/009852
[patent_app_country] => US
[patent_app_date] => 2004-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7356
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 238
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/267/07267943.pdf
[firstpage_image] =>[orig_patent_app_number] => 11009852
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/009852 | Methods for detecting bacteriophage MS2 | Dec 1, 2004 | Issued |
Array
(
[id] => 7178254
[patent_doc_number] => 20050123999
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-09
[patent_title] => 'Dihydroouabain-like factor and diagnostic & therapeutic compositions and methods'
[patent_app_type] => utility
[patent_app_number] => 10/988991
[patent_app_country] => US
[patent_app_date] => 2004-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13219
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20050123999.pdf
[firstpage_image] =>[orig_patent_app_number] => 10988991
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/988991 | Dihydroouabain-like factor and diagnostic & therapeutic compositions and methods | Nov 14, 2004 | Abandoned |
Array
(
[id] => 7075269
[patent_doc_number] => 20050148537
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-07
[patent_title] => 'Immunostimulatory nucleic acid molecules'
[patent_app_type] => utility
[patent_app_number] => 10/987146
[patent_app_country] => US
[patent_app_date] => 2004-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 21785
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20050148537.pdf
[firstpage_image] =>[orig_patent_app_number] => 10987146
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/987146 | Immunostimulatory nucleic acid molecules | Nov 11, 2004 | Abandoned |
Array
(
[id] => 5743118
[patent_doc_number] => 20060088843
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-27
[patent_title] => 'Modified venom and venom components as anti-retroviral agents'
[patent_app_type] => utility
[patent_app_number] => 10/883834
[patent_app_country] => US
[patent_app_date] => 2004-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10498
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0088/20060088843.pdf
[firstpage_image] =>[orig_patent_app_number] => 10883834
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/883834 | Modified venom and venom components as anti-retroviral agents | Oct 24, 2004 | Abandoned |
Array
(
[id] => 6957952
[patent_doc_number] => 20050214322
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-29
[patent_title] => 'Vaccines containing a saponin and a sterol'
[patent_app_type] => utility
[patent_app_number] => 10/967395
[patent_app_country] => US
[patent_app_date] => 2004-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4903
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20050214322.pdf
[firstpage_image] =>[orig_patent_app_number] => 10967395
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/967395 | Vaccines containing a saponin and a sterol | Oct 17, 2004 | Abandoned |
Array
(
[id] => 5726831
[patent_doc_number] => 20060057591
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-16
[patent_title] => 'Method for preventing viral infection'
[patent_app_type] => utility
[patent_app_number] => 10/940642
[patent_app_country] => US
[patent_app_date] => 2004-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 9162
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0057/20060057591.pdf
[firstpage_image] =>[orig_patent_app_number] => 10940642
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/940642 | Method for preventing viral infection | Sep 14, 2004 | Abandoned |
Array
(
[id] => 5224713
[patent_doc_number] => 20070253979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-01
[patent_title] => 'Immunogenic Hiv Compositions and Related Methods'
[patent_app_type] => utility
[patent_app_number] => 10/570177
[patent_app_country] => US
[patent_app_date] => 2004-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 16455
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0253/20070253979.pdf
[firstpage_image] =>[orig_patent_app_number] => 10570177
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/570177 | Immunogenic Hiv Compositions and Related Methods | Aug 26, 2004 | Abandoned |
Array
(
[id] => 6918758
[patent_doc_number] => 20050096319
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-05
[patent_title] => 'Identification of compounds that inhibit replication of human immunodeficiency virus'
[patent_app_type] => utility
[patent_app_number] => 10/920831
[patent_app_country] => US
[patent_app_date] => 2004-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 57255
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20050096319.pdf
[firstpage_image] =>[orig_patent_app_number] => 10920831
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/920831 | Identification of compounds that inhibit replication of human immunodeficiency virus | Aug 17, 2004 | Abandoned |
Array
(
[id] => 7426688
[patent_doc_number] => 20040265801
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-30
[patent_title] => 'Immunoassays for anti-HCV antibodies'
[patent_app_type] => new
[patent_app_number] => 10/899715
[patent_app_country] => US
[patent_app_date] => 2004-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 21882
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0265/20040265801.pdf
[firstpage_image] =>[orig_patent_app_number] => 10899715
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/899715 | Immunoassays for anti-HCV antibodies | Jul 25, 2004 | Issued |
Array
(
[id] => 111869
[patent_doc_number] => 07713535
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-11
[patent_title] => 'Modulation of immunostimulatory properties by small oligonucleotide-based compounds'
[patent_app_type] => utility
[patent_app_number] => 10/852598
[patent_app_country] => US
[patent_app_date] => 2004-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 40
[patent_no_of_words] => 22176
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/713/07713535.pdf
[firstpage_image] =>[orig_patent_app_number] => 10852598
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/852598 | Modulation of immunostimulatory properties by small oligonucleotide-based compounds | May 23, 2004 | Issued |
Array
(
[id] => 6925392
[patent_doc_number] => 20050238647
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-27
[patent_title] => 'Therapeutic uses for MDC and MDC antagonists'
[patent_app_type] => utility
[patent_app_number] => 10/818952
[patent_app_country] => US
[patent_app_date] => 2004-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 39416
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0238/20050238647.pdf
[firstpage_image] =>[orig_patent_app_number] => 10818952
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/818952 | Therapeutic uses for MDC and MDC antagonists | Apr 5, 2004 | Abandoned |
Array
(
[id] => 7383742
[patent_doc_number] => 20040180050
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-16
[patent_title] => 'Inverse skewing of the lymphocyte repertoire for therapy and prevention of disease'
[patent_app_type] => new
[patent_app_number] => 10/808789
[patent_app_country] => US
[patent_app_date] => 2004-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11552
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20040180050.pdf
[firstpage_image] =>[orig_patent_app_number] => 10808789
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/808789 | Inverse skewing of the lymphocyte repertoire for therapy and prevention of disease | Mar 22, 2004 | Abandoned |
Array
(
[id] => 4999364
[patent_doc_number] => 20070041998
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-22
[patent_title] => 'Use of alum and a th1 immune response inducing adjuvant for enhancing immune responses'
[patent_app_type] => utility
[patent_app_number] => 10/550820
[patent_app_country] => US
[patent_app_date] => 2004-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5088
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20070041998.pdf
[firstpage_image] =>[orig_patent_app_number] => 10550820
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/550820 | Use of alum and a th1 immune response inducing adjuvant for enhancing immune responses | Mar 21, 2004 | Abandoned |
Array
(
[id] => 5624881
[patent_doc_number] => 20060263386
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-23
[patent_title] => 'Vaccines'
[patent_app_type] => utility
[patent_app_number] => 10/550754
[patent_app_country] => US
[patent_app_date] => 2004-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 10262
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0263/20060263386.pdf
[firstpage_image] =>[orig_patent_app_number] => 10550754
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/550754 | Vaccines | Mar 21, 2004 | Issued |
Array
(
[id] => 5699618
[patent_doc_number] => 20060216302
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-28
[patent_title] => 'Immunological markers'
[patent_app_type] => utility
[patent_app_number] => 10/547046
[patent_app_country] => US
[patent_app_date] => 2004-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17119
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0216/20060216302.pdf
[firstpage_image] =>[orig_patent_app_number] => 10547046
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/547046 | Immunological markers | Feb 26, 2004 | Abandoned |
Array
(
[id] => 7677170
[patent_doc_number] => 20040152656
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-05
[patent_title] => 'Immunomodulatory oligonucleotides'
[patent_app_type] => new
[patent_app_number] => 10/788191
[patent_app_country] => US
[patent_app_date] => 2004-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11312
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20040152656.pdf
[firstpage_image] =>[orig_patent_app_number] => 10788191
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/788191 | Immunomodulatory oligonucleotides | Feb 25, 2004 | Abandoned |
Array
(
[id] => 7672886
[patent_doc_number] => 20040180893
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-16
[patent_title] => 'Identification of compounds that inhibit replication of human immunodeficiency virus'
[patent_app_type] => new
[patent_app_number] => 10/783053
[patent_app_country] => US
[patent_app_date] => 2004-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 29301
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20040180893.pdf
[firstpage_image] =>[orig_patent_app_number] => 10783053
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/783053 | Identification of compounds that inhibit replication of human immunodeficiency virus | Feb 18, 2004 | Abandoned |